Abattis Prepares for Growth in Extracts
Ryan Allway
September 20th, 2017
Exclusive, News, Top News
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis next year. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts.
In this article, we will look at Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) and why its proprietary extraction technology represents an important breakthrough that investors shouldn’t ignore.
Proprietary Extraction Technology
Abattis recently signed an exclusive distribution agreement with Suzhou Raybot Material Tech Corp (“Raybot”). Under the terms of the agreement, Abattis will use Raybot’s proprietary extraction technology in its own operations and have the exclusive rights to sell the extraction equipment and services to other companies. The agreement could open the door to mass produced cannabinoid products as well as licensing opportunities with other producers.
Raybot’s proprietary technology utilizes industrial column chromatography to extract and separate a wide range of materials in a continuous closed loop system. While the method is already used to mass produce extracts like Ginkgo Biloba and Stevia, the technology has been altered to extract legal cannabis derivatives like cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) from marijuana or hemp.
The proprietary technology uses a process known as low pressure preparatory column chromatography, which involves passing a pressurized liquid through a proprietary and exclusive polymer. Each component of the sample material interacts slightly differently with the polymer, causing different frequencies depending on the polarization for each component, which leads to the separation of the components as they flow out of the pressurized column.
Significant Advantages
Raybot’s proprietary extraction technology is capable of extracting CBD from hemp at a greater than 99% purity level. While the current methods use multi-staged CO2 extraction, the Raybot technology is significantly more cost-effective and can be customized to any factory production scale. For example, a processing center with a 5,000 kilograms per day processing rate could produce CBD at just $0.20 per gram using the technology. Raybot is able to achieve these cost advantages due to their ability to reuse and replenish the polymers for the columns. Abattis has exclusive distribution and service rights to replenish the polymers for extractions machines sold in North America and Europe.
In addition to these cost and scalability benefits, the technology can be used with both wet and dry products, which eliminates the need to dry cannabis products. Drying of the cannabis flower is not only expensive and time consuming, but could also lead to loss of terpenes and other active ingredients. The Raybot technology isolates only the desired active ingredients and removes all impurities, such as pesticides, without chemically altering the cannabinoids that are extracted, resulting in the purest formulations.
“This technology has the potential to revolutionize the extraction process for THC, CBD and other cannabis derivatives globally,” said Abattis CEO Robert Abenante in a recent press release announcing the licensing agreement. “Raybot’s proprietary extraction method is currently one of the only extraction technologies that can extract high purity CBD on an industrial scale. Furthermore, it could lead to the full separation of individual compounds and derivatives at significantly lower costs than today’s widely used methods.”
Looking Ahead
Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) represents a unique investment opportunity in the cannabis extracts space. With their distribution agreement in place with Raybot, the company has access to cutting-edge technology that enables the scalable production of highly purified cannabinoids at an extremely low cost. These benefits dovetail nicely with the company’s other downstream products and services, discussed in an earlier article.
Investors may want to take a closer look at the stock as the company gears up to scale its cannabis extracts business and create tremendous value in the cannabis industry. The company’s Northern Vine subsidiary plans to provide extraction, testing, analysis, formulation and other services to licensed producers in Canada to develop co-branded and white-label products.
For more information, visit the company’s website at www.abattis.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Mindleap is developing an advanced digital health platform that will provide support for people that are looking to achieve personal transformations and overcome mental health challenges.
Xtraction Services provides state-of-the-art, fully-automated, supercritical CO2 extraction machines with on-site staffing at no upfront cost, and a simple volume-based pricing model.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
